Serum adiponectin concentration in relation to body fat distribution and tissue insulin sensitivity in the glucose clamp study

National Medical Journal of China

Volumn 85, Issue 21, 2005, Pages 1456-1459

  Chen, Lei ^a   Xiang, Kun San ^a   Jia, Wei Ping ^a   Lu, Jun Xi ^a   Bao, Yu Qian ^a   Lu, Hui Juan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Adipocyte; Glucose clamp technique; Insulin

Indexed keywords

ADIPONECTIN; FATTY ACID; GLUCOSE; GLYCOGEN; INSULIN;

ADULT; AGE; ARTICLE; BODY FAT; BODY MASS; CHINA; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DIET RESTRICTION; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE; GLYCOGEN SYNTHESIS; HIP; HUMAN; HYPERINSULINEMIA; INSULIN SENSITIVITY; LIPID STORAGE; MALE; OBESITY; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; REGRESSION ANALYSIS; SEX; STEADY STATE; SUBCUTANEOUS FAT; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADIPOSE TISSUE; ADULT; BODY COMPOSITION; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT;

EID: 21244431536     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab, 2001, 86: 1930-1935.
2. Jia WP, Chen L, Xiang KS, et al. Establishment of an extended hyperinsulinemic euglycemic clamp, technique. Chin J Endocrinol Metab, 2001, 17: 268-271.
3. Jia WP, Xiang KS, Wu SH, et al. Metabolic features of intraabdominal obesity with or without NIDDM. Chin J Diabetes, 1995, 3: 11-14.
4. Finegood DT, Bergman RN, Vranic M. Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates. Diabetes, 1987, 36: 914-924.
5. Simonson DC, DeFronzo RA. Indirect calorimetry: methodological and interpretative problems. Am J Physiol, 1990, 258: E399-E412.
6. Yamauchi T, Kamon J, Wald H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med, 2001, 7: 941-946.
7. Kubota N, Terauchi Y, Yamauchi T, et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem, 2002, 277: 25863-25866.
8. Maeda N, Takahashi M, Funahashi T, et al. PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes, 2001, 50: 2094-2099.
9. Yu JG, Javorschi S, Hevener AL, et al. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes, 2002, 51: 2968-2974.
10. Kahn BB, Alquier T, Carling D, et al. AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab, 2005,1: 15-25.
11. Tsuchida A, Yamauchi T, Kadowaki T. Nuclear receptors as targets for drug development: molecular mechanisms for regulation of obesity and insulin resistance by peroxisome proliferator-activated receptor γ, CREB-binding protein, and adiponectin. J Pharmacol Sci, 2005, 97: 164-170.